Theory Paper IDrNB Cardiology – Theory Notes

PRE OP ASSESSMENT OF TOF; CURRENT STATUS; RECOMMENDATIONS

2-page exam answerLast reviewed: October 2026
Merit MedScript seal

IINTRODUCTION AND EMBRYOLOGICAL DEFINITION

  • Morphogenetic Definition (Van Praagh Monology): Tetralogy of Fallot (TOF) is the most common cyanotic congenital heart defect beyond the neonatal period, resulting from a single primary developmental abnormality: anterocephalad (anterior and superior) malalignment/deviation of the outlet (infundibular/conal) septum relative to the trabecular muscular septum. This single embryological shift produces all four components of the tetrad: (1) a large non-restrictive subaortic malalignment Ventricular Septal Defect (VSD), (2) Right Ventricular Outflow Tract (RVOT) obstruction (subvalvular infundibular, valvular, and/or supravalvular), (3) overriding of the aorta (less than 50 percent override over the RV; >50 percent RV origin is classified as Double Outlet Right Ventricle [DORV]), and (4) concentric Right Ventricular Hypertrophy (RVH) secondary to systemic RV pressure.
  • Objectives of Pre-Operative Assessment: To define every level of RVOT and branch pulmonary artery stenosis, measure the pulmonary valve annulus Z-score, exclude anomalous coronary arteries crossing the RVOT, identify additional muscular VSDs or aortopulmonary collaterals, screen for genetic syndromes (22q11.2 deletion), and select the optimal timing for valve-sparing primary repair vs. staged palliation.

IIPRE-OPERATIVE RISK STRATIFICATION

AHigh-Risk Anatomical Features (Dictating Surgical Modification)

  • Anomalous Coronary Artery Crossing the RVOT (Present in 5 to 9 Percent of TOF): Most commonly an anomalous Left Anterior Descending (LAD) artery arising from the Right Coronary Artery (RCA) or right sinus of Valsalva, a single coronary ostium, or a large dual LAD/conal branch coursing directly across the anterior subpulmonary infundibulum. Surgical Impact: Precludes a standard transannular ventriculotomy incision (as inadvertent transection causes fatal intraoperative anterior myocardial infarction); mandates either a transatrial-transpulmonary repair, a tailored oblique ventriculotomy parallel to the coronary, a double-barrel technique, or an extracardiac RV-to-PA conduit.
  • Hypoplastic Branch Pulmonary Arteries and Annular Z-Score:
    • Pulmonary Valve Annulus Z-Score: A Z-score greater than -2 to -3 generally permits valve-sparing repair, whereas a severely hypoplastic annulus (Z-score less than -3 to -4) predicts the requirement for a Transannular Patch (TAP).
    • Nakata Index (PAI) and McGoon Ratio: A Nakata Index less than 150 mm2/m2 or McGoon Ratio less than 1.2 indicates severe branch pulmonary artery hypoplasia, predicting suprasystemic post-repair RV pressure and favoring initial palliation (RVOT stent or mBTT shunt) to grow the pulmonary arterial tree before VSD closure.
    • Major Aortopulmonary Collateral Arteries (MAPCAs) and Discontinuous PAs: Present in TOF with Pulmonary Atresia (PA-VSD); mandates complete preoperative CTA + catheter mapping to plan surgical unifocalization.
    • Additional (“Swiss-Cheese”) Apical Muscular VSDs or Complete AVSD (“Tet-Canal”): Unrecognized second muscular VSDs cause acute postoperative left-to-right volume overload and heart failure after RVOT relief, while TOF with complete Atrioventricular Septal Defect (strongly associated with Down Syndrome / Trisomy 21) requires complex two-patch or modified single-patch repair.

BClinical, Syndromic, and STAT Mortality Risk Factors

  • Patient Factors: Prematurity, low birth weight (less than 2.5 kg), and prostaglandin-dependent neonatal cyanosis or refractory ventilated hypercyanotic spells carry higher morbidity with neonatal bypass and often favor initial transcatheter RVOT/PDA stenting.
  • Genetic Syndromes (Present in 20 to 30 Percent of TOF):
    • 22q11.2 Microdeletion (DiGeorge / Velocardiofacial Syndrome — Present in ~15% of classical TOF and up to 40–50% of TOF with Pulmonary Atresia or Right Aortic Arch): Mandates preoperative screening (FISH / chromosomal microarray) because thymic hypoplasia requires irradiated, leukoreduced blood products (to prevent fatal transfusion-associated graft-versus-host disease), parathyroid hypoplasia causes severe perioperative hypocalcemia, and velopharyngeal/airway anomalies complicate extubation.
    • Other Associations: Trisomy 21 (associated with TOF + AVSD), Alagille Syndrome (JAG1) (peripheral branch PA stenosis + cholestasis), and CHARGE / VACTERL associations.
    • STAT Mortality Categories (Society of Thoracic Surgeons — EACTS): Standard primary TOF repair is STAT Category 1 to 2 (operative mortality ~1 percent), whereas TOF with Pulmonary Atresia and MAPCAs or neonatal repair with severe comorbidities rises to STAT Category 4.

IIIMULTIMODALITY PRE-OPERATIVE DIAGNOSTIC ALGORITHM

Imaging Modality Guideline Status Specific Pre-Operative Parameters Evaluated
Transthoracic Echocardiography (TTE) Class I (Mandatory First-Line in All Patients) Malalignment VSD size & <50% aortic override (excludes DORV); multilevel RVOT obstruction; PV annulus diameter & Z-score; proximal coronary origins; Right Aortic Arch (present in 25%); additional muscular VSDs, ASD/PFO, PDA, and Left SVC to Coronary Sinus (10%)
Cardiac CT Angiography (MDCTA) Class I / IIa (Non-Invasive Reference for Extracardiac & Coronary Anatomy) Definitive exclusion of anomalous LAD crossing RVOT; 3D branch PA measurements (Nakata Index & McGoon Ratio); aortic arch branching (aberrant subclavian artery); and complete mapping of MAPCAs
Cardiac Catheterization & Angiography Class III for Routine Uncomplicated TOF; Class I for Specific Hemodynamic/Interventional Indications Reserved for: (1) TOF with PA & MAPCAs (measuring distal segmental MAPCA pressures and proving dual vs. sole supply); (2) Coiling large dual-supply APCs; (3) RVOT or PDA stenting; or (4) assessing PVR in rare late-presenting pink TOF

IVPRE-OPERATIVE MEDICAL STABILIZATION AND TET SPELL PROTOCOL

  • Hypercyanotic Spell Emergency Protocol:
    • Physical Maneuver & Oxygen: Knee-chest position (increases SVR) and 100% humidified oxygen.
    • Sedation and Hyperpnea Suppression: Morphine Sulfate 0.1 to 0.2 mg/kg IV, IM, or SC (or Ketamine 1 to 2 mg/kg IV / 3 to 5 mg/kg IM).
    • Volume Expansion and Acidosis Correction: Isotonic crystalloid bolus 10 to 20 mL/kg IV (increases RV preload) and Sodium Bicarbonate 1 to 2 mEq/kg IV if metabolic acidosis persists.
    • Relief of Dynamic Infundibular Spasm (Class I): Esmolol 500 mcg/kg (0.5 mg/kg) IV bolus over 1 minute followed by 50 to 200 mcg/kg/min infusion, or Propranolol 0.05 to 0.15 mg/kg slow IV push.
    • SVR Augmentation (Refractory Spells): Phenylephrine 5 to 20 mcg/kg IV bolus followed by 0.1 to 0.5 mcg/kg/min infusion.
    • Outpatient Pre-Surgical Optimization: Oral Propranolol (1 to 4 mg/kg/day) for spell prophylaxis, oral iron supplementation (to maintain MCV >80 fL and prevent microcytic hyperviscosity stroke), dental/infection clearance, and avoidance of dehydration.

VCURRENT SURGICAL TIMING AND VALVE-SPARING RECOMMENDATIONS (AATS / STS CONSENSUS)

  • Elective Primary Repair at 3 to 6 Months of Age (Class I): Asymptomatic or mildly cyanotic infants with standard anatomy undergo elective single-stage complete repair between 3 and 6 months of age (performing repair before 3 months increases transannular patch rates and ICU stay, while delaying beyond 12 months increases chronic hypoxia, RV hypertrophy/fibrosis, and spell morbidity).
  • Symptomatic Neonates (<30 Days) or Weight <2.5 kg: High-volume neonatal centers may perform primary neonatal repair in selected cases, but staged palliation—preferentially via transcatheter RVOT Stenting (or PDA stenting / surgical mBTT shunt)—followed by complete repair at 4 to 8 months achieves lower early morbidity and allows the pulmonary annulus to grow for a subsequent valve-sparing repair.
  • The Valve-Sparing Transatrial-Transpulmonary Paradigm: To prevent late RV failure from chronic free pulmonary regurgitation, contemporary surgery prioritizes a transatrial-transpulmonary approach combining infundibular muscle resection through the tricuspid valve, pulmonary commissurotomy, and intraoperative balloon dilation of the pulmonary annulus to preserve the native valve whenever the pulmonary annulus Z-score is -2.5 to -3.0 or greater.

Key references

  • Expert Consensus Panel (Villafañe J, Feinstein JA, Jenkins KJ, et al.): Hot Topics in Tetralogy of Fallot, Journal of the American College of Cardiology, 2013.
  • Miller JR, Stephens EH, Goldstone AB, et al. (AATS Expert Consensus): The American Association for Thoracic Surgery (AATS) 2022 Expert Consensus Document: Management of infants and neonates with tetralogy of Fallot, Journal of Thoracic and Cardiovascular Surgery, 2023.
  • Baumgartner H, De Backer J, Babu-Narayan SV, et al.: 2020 ESC Guidelines for the management of adult congenital heart disease, European Heart Journal, 2020.
meritmedscript.comDr. Sidhartha Mullapudi

Was this answer useful?

Your rating helps decide which topics to expand next.

Report an error

Spotted something outdated or incorrect? Tell us and we will check it against the source.